~ Buy the BEVESPI AEROSPHERE (formoterol fumarate; glycopyrrolate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR BEVESPI AEROSPHERE

All Clinical Trials for BEVESPI AEROSPHERE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT03081156 ↗	The Effect of BEVESPI AEROSPHERE ® Therapy on Exercise Tolerance in COPD	Completed	Los Angeles Biomedical Research Institute	Phase 4	2017-03-27	This trial is an investigator initiated study involving the use of the AstraZenica Aerophere Inhaler (Glycopyrrolate/Formoterol) to determine the effect on exercise tolerance and dynamic hyperinflation in patients with chronic obstructive lung disease.
NCT03081156 ↗	The Effect of BEVESPI AEROSPHERE ® Therapy on Exercise Tolerance in COPD	Completed	Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center	Phase 4	2017-03-27	This trial is an investigator initiated study involving the use of the AstraZenica Aerophere Inhaler (Glycopyrrolate/Formoterol) to determine the effect on exercise tolerance and dynamic hyperinflation in patients with chronic obstructive lung disease.
NCT03324607 ↗	Effects of Bevespi on Ventilation and Gas Exchange Abnormalities in COPD Assessed by 129Xe MRI	Completed	Bastiaan Driehuys	Phase 2/Phase 3	2018-04-20	The purpose of this study is to determine whether the new inhaler, Bevespi improves lung function. Magnetic resonance imaging (MRI) using inhaled hyperpolarized 129Xe gas, that can provide useful images of the functioning of the lung will be used as a new measure to determine change in function. The investigator anticipate these images will provide more specific information about lung disease than standard lung function tests in response to treatment.

Clinical Trial Conditions for BEVESPI AEROSPHERE

Condition Name

Condition Name for BEVESPI AEROSPHERE
Intervention	Trials
COPD	1
Pulmonary Disease, Chronic Obstructive	1

Condition MeSH

Condition MeSH for BEVESPI AEROSPHERE
Intervention	Trials
Lung Diseases	1
Chronic Disease	1
Congenital Abnormalities	1
Pulmonary Disease, Chronic Obstructive	1

Clinical Trial Locations for BEVESPI AEROSPHERE

Trials by Country

Trials by Country for BEVESPI AEROSPHERE
Location	Trials
United States	2

Trials by US State

Trials by US State for BEVESPI AEROSPHERE
Location	Trials
North Carolina	1
California	1

Clinical Trial Progress for BEVESPI AEROSPHERE

Clinical Trial Phase

Clinical Trial Phase for BEVESPI AEROSPHERE
Clinical Trial Phase	Trials
Phase 4	1
Phase 2/Phase 3	1

Clinical Trial Status

Clinical Trial Status for BEVESPI AEROSPHERE
Clinical Trial Phase	Trials
Completed	2

Clinical Trial Sponsors for BEVESPI AEROSPHERE

Sponsor Name

Sponsor Name for BEVESPI AEROSPHERE
Sponsor	Trials
Los Angeles Biomedical Research Institute	1
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center	1
Bastiaan Driehuys	1

Sponsor Type

Sponsor Type for BEVESPI AEROSPHERE
Sponsor	Trials
Other	3